Sudhanshu Shekhar
Czech Academy of Sciences, Institute of Microbiology, University of Oslo, University of Manitoba, University of Oxford
0000-0003-3187-2496
About
Dr. Sudhanshu Shekhar is a Researcher at the Laboratory of Gnotobiology, Institute of Microbiology, Czech Academy of Sciences, Czech Republic, where his work focuses on gnotobiology and the therapeutic potential of the nasal microbiota. He holds an MSc in Integrated Immunology from the University of Oxford (UK) and a PhD in Infection and Immunity from the University of Manitoba (Canada).
Prior to his current role, Dr. Shekhar was a Postdoctoral Researcher and subsequently a Senior Researcher (≈Associate Professor) at the University of Oslo, Norway, where his research focused on the development of commensal bacteria-based live vaccines and the impact of antimicrobials on infant and neonatal lung immunity.
His broader research interests center on harnessing host-microbe interactions in the respiratory tract to develop innovative therapeutic strategies for airway allergic diseases and antimicrobial resistance (AMR). Of note, Dr. Shekhar is also a trained veterinarian and serves as an Editor for Folia Microbiologica (Springer Nature).
Employment
-
Czech Academy of Sciences, Institute of Microbiology Researcher2024 - Present
-
University of Oslo Senior Researcher2019 - 2022
-
University of Oslo Postdoctoral Researcher2015 - 2018
Education
-
University of Manitoba PhD2010 - 2015
-
University of Oxford MSc2006 - 2007
Projects & Funding
Projects & funding information is unavailable.
Publications (33)
- Intranasal Colonization of Germ-Free Mice with Human Nasal Microbial Communities Save
- Nasal microbiota transplantation: a gateway to novel treatments Save
- Enhancement of Macrophage Immunity against Chlamydial Infection by Natural Killer T Cells Save
- HAMLET, a human milk protein-lipid complex, modulates amoxicillin induced changes in an ex vivo biofilm model of the oral microbiome Save
- Suppressive effect of therapeutic antibiotic regimen on antipneumococcal Th1/Th17 responses in neonatal mice Save
- Treatment of Mouse Infants with Amoxicillin, but Not the Human Milk-Derived Antimicrobial HAMLET, Impairs Lung Th17 Responses Save
- Effects of different amoxicillin treatment durations on microbiome diversity and composition in the gut Save
- Vaccination With the Commensal Streptococcus mitis Expressing Pneumococcal Serotype 5 Capsule Elicits IgG/IgA and Th17 Responses Against Streptococcus pneumoniae Save
- Semaphorin 3E Protects against Chlamydial Infection by Modulating Dendritic Cell Functions Save
- The Dark Side of Antibiotics: Adverse Effects on the Infant Immune Defense Against Infection Save